Skip to main content
ONO PHARMACEUTICAL CO., LTD.

Corporate Report Online

  • Japanese
  • English

Corporate Report 2025

ONO
  • Message
  • Round-table Discussion
  • PDF download

Message

Message from the CEO

Evolving into a Company that
Continuously Takes on
Challenges in the Global
Market and Continues to Create
New Value

Gyo Sagara Representative Director,
Chairman of the Board and Chief Executive Officer

Message from the COO

Continuing to Embrace
Challenges in Unknown Fields,
Becoming a Company that
Delivers New Value to Global
Healthcare

Toichi Takino Representative Director,
President and Chief Operating Officer

Round-table Discussion

Governance System Supporting Challenge and Transformation
toward Becoming a Global Specialty Pharma
—External Directors Discuss the Past and Future of Ono

  • Akiko Okuno Outside DirectorProfessor, Faculty of Business Administration,
    KONAN UNIVERSITY
  • Masao NomuraOutside DirectorCorporate Advisor, Iwatani Corporation
    Outside Director, Keihanshin Building Co., Ltd.
  • Shusaku NagaeOutside DirectorSpecial Corporate Advisor, Panasonic Holdings
    Corporation
    Outside Audit & Supervisory Board Member,
    Nikkei Inc.

PDF download

FY2025
Full Report (A4) 13.1MB
  • FY2024 (15.4MB)

    FY2024

  • FY2023 (7.88MB)

    FY2023

  • FY2022 (10.4MB)

    FY2022

  • FY2021 (8.8MB)

    FY2021

  • FY2020 (6.9MB)

    FY2020

  • FY2019 (5.5MB)

    FY2019

  • FY2018 (5.5MB)

    FY2018

  • FY2017 (8.2MB)

    FY2017

  • FY2016 (6.9MB)

    FY2016

  • FY2015 (8.2MB)

    FY2015

  • FY2014 (3.1MB)

    FY2014

  • FY2013 (5.1MB)

    FY2013

  • FY2012 (3.3MB)

    FY2012

  • FY2011 (2.9MB)

    FY2011

  • FY2010 (2.9MB)

    FY2010

  • FY2009 (789KB)

    FY2009

Copyright ©2025 Ono Pharmaceutical Co., Ltd. All Rights Reserved.